|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600117746 |
|
最近更新日期: Date of Last Refreshed on: |
2026-01-28 11:20:32 |
|
注册时间: Date of Registration: |
2026-01-28 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
脑卒中患者与照顾者二元自我护理分类干预模式研究 |
|
Public title: |
A study on the dyadic self-care subgroup classified intervention model between stroke survivor-caregiver dyads |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
脑卒中患者与照顾者二元自我护理交互模型构建及阶梯式干预模式研究 |
|
Scientific title: |
A study on the dyadic self-care interaction model and step-by-step intervention model between stroke survivor-caregiver dyads |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
宋王涛 |
研究负责人: |
张振香 |
|
Applicant: |
Wangtao Song |
Study leader: |
Zhenxiang Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 136 1384 7827 |
研究负责人电话:
Study leader's |
+86 133 0381 6666 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1229104697@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
zhangzx6666@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河南省郑州市高新区科学大道101号 |
研究负责人通讯地址: |
河南省郑州市高新区科学大道101号 |
|
Applicant address: |
No.101, Kexuedadao Road, Zhengzhou City, Henan Province |
Study leader's address: |
No.101, Kexuedadao Road, Zhengzhou City, Henan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
450001 |
研究负责人邮政编码: Study leader's postcode: |
450001 |
|
申请人所在单位: |
郑州大学护理与健康学院 |
||
|
Applicant's institution: |
School of Nursing and Health,Zhengzhou University |
||
|
研究负责人所在单位: |
郑州大学护理与健康学院 |
||
|
Affiliation of the Leader: |
School of Nursing and Health,Zhengzhou University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
ZZUIRB 2021-115 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
郑州大学生命科学伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethic Committee, Zhengzhou University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-01-01 00:00:00 | ||
|
伦理委员会联系人: |
郑州大学综合管理中心 426 房间 |
||
|
Contact Name of the ethic committee: |
Room 426, Integrated Management Center, Zhengzhou University |
||
|
伦理委员会联系地址: |
河南省郑州市高新区科学大道101号 |
||
|
Contact Address of the ethic committee: |
No.101, Kexuedadao Road, Zhengzhou City, Henan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 67739539 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
xswyh@zzu.edu.cn |
|
研究实施负责(组长)单位: |
郑州大学护理与健康学院 |
||||||||||||||||||||||
|
Primary sponsor: |
School of Nursing and Health,Zhengzhou University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河南省郑州市高新区科学大道101号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.101, Kexuedadao Road, Zhengzhou City, Henan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金项目(72174184) |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (Grant number: 72174184) |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
Stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1)构建脑卒中患者与照顾者二元自我护理分类干预方案。 (2)评价脑卒中患者与照顾者二元自我护理分类干预方案对改善脑卒中患者与照顾者二元自我护理行为、二者生活质量和照顾者负担的干预效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) Construct a binary self-care classification intervention program for stroke patients and their caregivers. (2) To evaluate the effect of the binary self-care classification intervention program for stroke patients and their caregivers on improving the binary self-care behavior of stroke patients and their caregivers, their quality of life and the burden of caregivers. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)脑卒中患者纳入标准:1)符合《中国各类主要脑血管病诊断要点2019》[80]脑卒中诊断标准,经颅脑CT或MRI确诊为脑卒中;2)年龄≥18岁;3)病情稳定,具有一定自理能力(改良版Barthel指数量表得分>60分[81]);4)认知正常(MMSE得分≥17分[82]),无明显沟通障碍(Token测试量表得分≥17分[83]);5)知情同意,自愿参与本研究;6)能够使用智能手机微信软件。 (2)脑卒中患者照顾者纳入标准:1)承担脑卒中患者主要照顾任务的非正式照顾者(如患者的配偶、子女等);2)年龄≥18岁;3)认知功能正常(MMSE得分≥17分),能正确清晰地回答问题(Token测试量表得分≥17分);4)承担患者主要照护责任,每日照顾患者时间≥4小时;5)知情同意,自愿参与;6)能够使用智能手机微信软件。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria of stroke patients: 1. patients met the diagnostic criteria of stroke in "The Diagnostic points of Major Cerebrovascular Diseases in China 2019" [80], and stroke was diagnosed by brain CT or MRI; 2. age >=18 years old; 3.stable condition with certain self-care ability (modified Barthel index score >60 points [81]); 4. normal cognition (MMSE score >=17 points [82]), no obvious communication disorder (Token test scale score >=17 points [83]); 5.Informed consent and voluntary participation in the study; 6. Able to use wechat software on smart phones. Inclusion criteria of caregivers of stroke patients: 1. Informal caregivers (such as spouses, children, etc.) who undertake the main care tasks of stroke patients;2. age >=18 years old; 3. normal cognitive function (MMSE score >=17 points) and able to answer questions correctly and clearly (Token test scale score >=17 points); 4. bear the main care responsibility for patients, and take care of patients for more than 4 hours per day; 5. informed consent and voluntary participation; ⑥ Able to use wechat software on smart phones. |
||||||||||||||||||||||
|
排除标准: |
(1)患者排除标准:1)伴有其他危重疾病者,如恶性肿瘤、心功能衰竭、肾功能衰竭、呼吸功能衰竭、严重外伤等其他危重病症者;2)正在参与其他研究者。 (2)照顾者排除标准:因个人原因不能配合调查。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patinets' exclusion criteria: 1.Patients with other critical diseases, such as malignant tumors, heart failure, renal failure, respiratory failure, severe trauma and other critical diseases; 2. Participating in other investigators. Caregivers' exclusion criteria: unable to cooperate with the survey due to personal reasons. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-12-01 00:00:00至 To 2026-01-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-03-15 00:00:00 至 To 2025-09-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
对满足纳入及排除标准的患者进行计算机算计化法,将参与者分为对照组和干预组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The patients who met the inclusion and exclusion criteria were calculated by computer, and the participants were divided into control group and intervention group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
本研究采用结局指标收集人员及统计分析人员盲法。 |
|
Blinding: |
This study was blinded by outcome measure collectors and statistical analysts. |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后6个月,经研究者同意后可邮箱获取; |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Six months after the study ends, it can be obtained via email with the researcher's consent. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集使用病历记录表,数据管理采用电子管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection uses medical record form, and data management uses electronic management system. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |